What is a stock summary page? Click here for an overview.
Business Description
Intech Biopharm Ltd
ISIN : TW0006461007
Description
Intech Biopharm Ltd is a biotechnology company. The company develops inhalation products including single or combination generic products and some new combinations or new formulation projects are under development. It develops drugs for the treatment of lung diseases such as asthma. It has operations in Taiwan, China, Hong Kong, and Others.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.76 | |||||
| Debt-to-EBITDA | -5.82 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.18 | |||||
| Beneish M-Score | -1.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8 | |||||
| 3-Year EBITDA Growth Rate | 1.6 | |||||
| 3-Year EPS without NRI Growth Rate | 2.5 | |||||
| 3-Year FCF Growth Rate | -2.3 | |||||
| 3-Year Book Growth Rate | -19.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.04 | |||||
| 9-Day RSI | 27.84 | |||||
| 14-Day RSI | 27.33 | |||||
| 3-1 Month Momentum % | -3.34 | |||||
| 6-1 Month Momentum % | -15.17 | |||||
| 12-1 Month Momentum % | -13.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.06 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.67 | |||||
| Days Inventory | 93.33 | |||||
| Days Sales Outstanding | 47.2 | |||||
| Days Payable | 12.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | 1.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -396.25 | |||||
| Operating Margin % | -895.26 | |||||
| Net Margin % | -925.63 | |||||
| FCF Margin % | -786.44 | |||||
| ROE % | -36.89 | |||||
| ROA % | -14.32 | |||||
| ROIC % | -14.51 | |||||
| 3-Year ROIIC % | 50.86 | |||||
| ROC (Joel Greenblatt) % | -17.6 | |||||
| ROCE % | -16.03 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 62.59 | |||||
| PB Ratio | 3.07 | |||||
| Price-to-Tangible-Book | 3.09 | |||||
| EV-to-EBIT | -11.02 | |||||
| EV-to-EBITDA | -14.92 | |||||
| EV-to-Revenue | 92.55 | |||||
| EV-to-FCF | -11.77 | |||||
| Price-to-GF-Value | 0.55 | |||||
| Earnings Yield (Greenblatt) % | -9.07 | |||||
| FCF Yield % | -12.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intech Biopharm Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 39.779 | ||
| EPS (TTM) (NT$) | -2.69 | ||
| Beta | -0.34 | ||
| 3-Year Sharpe Ratio | 0.26 | ||
| 3-Year Sortino Ratio | 0.49 | ||
| Volatility % | 29.64 | ||
| 14-Day RSI | 27.33 | ||
| 14-Day ATR (NT$) | 1.005751 | ||
| 20-Day SMA (NT$) | 22.095 | ||
| 12-1 Month Momentum % | -13.68 | ||
| 52-Week Range (NT$) | 16.5 - 34.6 | ||
| Shares Outstanding (Mil) | 137.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Intech Biopharm Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Intech Biopharm Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Intech Biopharm Ltd Frequently Asked Questions
What is Intech Biopharm Ltd(ROCO:6461)'s stock price today?
The current price of ROCO:6461 is NT$18.15. The 52 week high of ROCO:6461 is NT$34.60 and 52 week low is NT$16.50.
When is next earnings date of Intech Biopharm Ltd(ROCO:6461)?
The next earnings date of Intech Biopharm Ltd(ROCO:6461) is .
Does Intech Biopharm Ltd(ROCO:6461) pay dividends? If so, how much?
Intech Biopharm Ltd(ROCO:6461) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers